In @Nature: As early results from a clinical trial in the DRC suggest that the drug tecovirimat does not accelerate recovery for clade I #mpox, PSI's Professor Piero Olliaro says the final results could still provide hope for some groups.

Read more 👇
nature.com/articles/d4158…